GlaxoSmithKline has become the latest pharmaceuticals company to be accused of paying bribes to win business in China. In the past year, Eli Lilly and Pfizer have reached settlements with US authorities over similar allegations concerning their conduct in China.
葛蘭素史克（GlaxoSmithKline，簡稱GSK）成爲最新一家被控靠行賄在中國市場贏取業務的製藥公司。去年，禮來(Eli Lilly)和輝瑞(Pfizer)已就關於其在中國行爲的類似指控，與美國監管當局達成了和解。
您已閱讀12%（372字），剩餘88%（2828字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。